DEADLINE ALERT for AVYA, BLRX, ENVX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Author's Avatar
Feb 15, 2023

BENSALEM, Pa., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected].

Avaya Holdings Corp. (: AVYA)
Class Period: November 22, 2021 – November 29, 2022
Lead Plaintiff Deadline: March 6, 2023

The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's internal control over financial reporting ("ICFR") was deficient in several areas; (2) as a result of these deficiencies, the Company had failed to design and maintain effective controls over its whistleblower policies and its ethics and compliance program; (3) the Company's deteriorating financial condition was likely to raise substantial doubt as to its ability to continue as a going concern; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

BioLineRx Ltd. ( BLRX)
Class Period: February 23, 2021 – September 19, 2022
Lead Plaintiff Deadline: March 6, 2023

The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was not well financed to develop Motixafortide while at the same time advancing other pipeline programs; (2) BioLine would require a loan from Kreos Capital VII Aggregator SCSP in an aggregate principal amount of up to $40 million and then also would require a $15M securities offering to facilitate the commercial launch of Motixafortide; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Enovix Corporation ( ENVX)
Class Period: February 22, 2021 – January 3, 2023
Lead Plaintiff Deadline: March 7, 2023

The complaint alleges that throughout the Class Period the defendants overstated Enovix’s ability to produce batteries at scale and its ability to deliver batteries ahead of competition.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com

ti?nf=ODc0OTUwNyM1NDEwMzEzIzIwMjA0MzI=
Law-Offices-of-Howard-G-Smith.png